FAQ

1.What Exchange is Biovest traded on?
2.Who is Biovest’s transfer agent?
3.When does Biovest’s fiscal year end?
4.Who is Biovest’s independent registered public accounting firm?
5.What equity research analysts are currently covering Biovest?
6.How can I sign-up to receive Biovest’s press releases?
7.Who can I speak with regarding my specific questions?
1.What Exchange is Biovest traded on?
 Biovest trades on the OTCQB, a market tier for OTC-traded U.S. companies that are registered and reporting with the SEC. Investors can view real-time stock quotes at: http://www.otcmarkets.com

2.Who is Biovest’s transfer agent?
 Broadridge Corporate Issuer Solutions, Inc.
44 W. Lancaster Ave.
Ardmore, PA 19003
Phone: 877-830-4936
Fax: 610-649-7302
E-mail: shareholder@broadridge.com

3.When does Biovest’s fiscal year end?
 Biovest’s fiscal year ends on September 30th.

4.Who is Biovest’s independent registered public accounting firm?
 Cherry, Bekaert & Holland L.L.P.
Website: http://www.cbh.com

5.What equity research analysts are currently covering Biovest?
 ROTH Capital Partners, Joseph Pantginis Ph.D.

6.How can I sign-up to receive Biovest’s press releases?
 Please visit the “Contact Us” section of our website to request to be added to Biovest’s news distribution list.

7.Who can I speak with regarding my specific questions?
 Please call Doug Calder at 813-864-2558 or email him at dwcalder@biovest.com

BiovaxID®

Personalized cancer vaccine targeting certain B-cell lymphomas

BVTI Research Report

OneMedPlace initiates research on Biovest and BiovaxID lymphoma cancer vaccine

Media Center

Biovest headlines, videos, webcasts and feature articles